Looks like the gloves are finally coming off and someone is standing up to the FDA over their dysfunctional relationship to consumer health.
Whole Foods Magazine reports that the U.S. Food and Drug Administration (FDA)’s attempt to eliminate certain qualified health claims for selenium and reduced risk of cancer (see story).
Since then, the plot has thickened. On Friday, July 31, several plaintiffs (all represented by Emord & Associates, P.C. with Attorney Jonathan Emord serving as lead counsel) will bring a lawsuit against FDA claiming the agency’s ban of four such health claims violates the First Amendment. The statements include the use of selenium to reduce the risk of lung/respiratory tract cancers, to reduce the risk of prostate cancer, to reduce the risk of other cancers, and to produce anticarcinogenic effects in the body.
The group also feels FDA’s insistence on pairing a fifth claim (site-specific cancer risk reduction) “with an inaccurate and negatively value laden disclaimer†is unjust. The hope is that the U.S. District Court for the District of Columbia will find FDA’s censorship unconstitutional. Read the full story.
